跳至主要内容
临床试验/IRCT2014042117150N2
IRCT2014042117150N2已完成2 期

Placebo-controlled clinical trial to determine the effects of dietary zinc supplementation on serum levels of nerve growth factor in patients with diabetic retinopathy

Vice chancellor for Research, Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
All

入选标准

  • age range 40-70 years old; suffering from type 2 diabetes; subject diagnosed with diabetic retinopathy based on ETDRS and the DRS criteria.
  • Exclusion criteria: insulin injection; hving chronic diseases such as cardiovascular disorders, renal and hepatic,asthma and allergy; having malabsorption syndrome and inflammatory bowel disease; pregnancy and lactation; drugs interfering with zinc (Penicillin amine, Diethylenetriamine pentaacetate); receiving nutritional supplements from 2 months before the study (zinc, calcium, vitamin A and iron); exercise on a regular basis; having a mental illness such as depression; infectious diseases and AIDS; alcoholism.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for Research, Tabriz University of Medical Sciences

相似试验